newsfilter
← Latest News
ACCESS Newswire·

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)

Jaguar remains sharply focused on its ongoing global development program for oral crofelemer as adjunctive therapy to parenteral support for pediatric and adult rare IF diseases, including microvillus inclusion